VPC
ATRA icon

Vestal Point Capital’s Atara Biotherapeutics ATRA Stock Holding History

Vestal Point Capital’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-94,085
Closed -$726K – 82
2025
Q2 		$726K Hold
94,085
– – 0.04% 69
2025
Q1 		$559K Sell
94,085
-30,915
-25% -$270K 0.04% 59
2024
Q4 		$1.66M Buy
125,000
+323
+0.3% +$3.4K 0.1% 69
2024
Q3 		$1.01M Buy
124,677
+12,677
+11% +$109K 0.08% 68
2024
Q2 		$952K Hold
112,000
– – 0.07% 58
2024
Q1 		$1.94M Buy
+112,000
New +$1.99M 0.16% 53

Other funds holding ATRA

EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCA
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.36B AUM 23.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return